DK0750614T3 - Quinazolinyl-aminoderivater med alfa-antagonist-aktivitet - Google Patents
Quinazolinyl-aminoderivater med alfa-antagonist-aktivitetInfo
- Publication number
- DK0750614T3 DK0750614T3 DK95911342T DK95911342T DK0750614T3 DK 0750614 T3 DK0750614 T3 DK 0750614T3 DK 95911342 T DK95911342 T DK 95911342T DK 95911342 T DK95911342 T DK 95911342T DK 0750614 T3 DK0750614 T3 DK 0750614T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- amino derivatives
- quinazolinyl
- alpha
- antagonist activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI940506A IT1270993B (it) | 1994-03-18 | 1994-03-18 | Derivati chinzolilamminici attivi come alfa-antagonisti |
PCT/EP1995/001001 WO1995025726A1 (en) | 1994-03-18 | 1995-03-17 | QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0750614T3 true DK0750614T3 (da) | 2001-09-10 |
Family
ID=11368249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95911342T DK0750614T3 (da) | 1994-03-18 | 1995-03-17 | Quinazolinyl-aminoderivater med alfa-antagonist-aktivitet |
Country Status (15)
Country | Link |
---|---|
US (1) | US5798362A (da) |
EP (1) | EP0750614B1 (da) |
JP (1) | JP3683911B2 (da) |
AT (1) | ATE201400T1 (da) |
AU (1) | AU1894895A (da) |
DE (1) | DE69521037T2 (da) |
DK (1) | DK0750614T3 (da) |
ES (1) | ES2158938T3 (da) |
GR (1) | GR3036443T3 (da) |
IL (1) | IL113024A (da) |
IT (1) | IT1270993B (da) |
PT (1) | PT750614E (da) |
TW (1) | TW416951B (da) |
WO (1) | WO1995025726A1 (da) |
ZA (1) | ZA952208B (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747490A (en) * | 1995-09-29 | 1998-05-05 | Merck & Co., Inc. | Alpha 1b adrenergic receptor antagonists |
AU7692896A (en) * | 1995-12-01 | 1997-06-27 | Novartis Ag | Quinazolin-2,4-diazirines as NPY receptor antagonist |
IT1286302B1 (it) * | 1996-04-10 | 1998-07-08 | Rotta Research Lab | Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso |
GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
GB9711650D0 (en) * | 1997-06-05 | 1997-07-30 | Pfizer Ltd | Compounds useful in therapy |
US7186726B2 (en) * | 1998-06-30 | 2007-03-06 | Neuromed Pharmaceuticals Ltd. | Preferentially substituted calcium channel blockers |
US6355641B1 (en) | 1999-03-17 | 2002-03-12 | Syntex (U.S.A.) Llc | Oxazolone derivatives and uses thereof |
IT1312310B1 (it) * | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale |
ITMI20012060A1 (it) * | 2001-10-05 | 2003-04-05 | Recordati Chem Pharm | Nuovi eterocilcli n-acilati |
US7071197B2 (en) | 2002-06-14 | 2006-07-04 | Recordati S.A. | N,N-disubstituted diazocycloalkanes |
US20040058962A1 (en) * | 2002-06-14 | 2004-03-25 | Amedeo Leonardi | Phenylalkylamines and pyridylalkylamines |
US20040072839A1 (en) * | 2002-06-14 | 2004-04-15 | Amedeo Leonardi | 1-Phenylalkylpiperazines |
JP4769082B2 (ja) * | 2003-12-17 | 2011-09-07 | 武田薬品工業株式会社 | ウレア誘導体、その製造法及び用途 |
US20060264442A1 (en) * | 2005-05-18 | 2006-11-23 | Allergan, Inc. | Methods for the treatment of ocular and neurodegenerative conditions in a mammal |
ES2584702T3 (es) | 2012-06-20 | 2016-09-28 | Novartis Ag | Moduladores de ruta del complemento y usos de los mismos |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE925468C (de) * | 1941-08-13 | 1955-03-21 | Hoechst Ag | Verfahren zur Herstellung von ª†, ª†-Diaryl-propyl-aminen |
GB679676A (en) * | 1950-04-03 | 1952-09-24 | Dow Chemical Co | Improved method for the production of salts of aromatic-oxy-aliphatic carboxylic acids |
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
DE2143730A1 (de) * | 1971-09-01 | 1973-03-08 | Byk Gulden Lomberg Chem Fab | Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel |
US4044136A (en) * | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4062844A (en) * | 1976-09-20 | 1977-12-13 | Pfizer Inc. | Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines |
FR2389614A1 (en) * | 1977-05-05 | 1978-12-01 | Synthelabo | Antihypertensive 2,4-di:amino-quinazoline(s) - prepd. from a 2-halo-4-amino-quinazoline and a secondary amine |
US4607034A (en) * | 1979-10-29 | 1986-08-19 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinazoline derivatives and pharmaceutical composition thereof |
GB2068961B (en) * | 1980-02-13 | 1983-11-30 | Sankyo Co | Quinazoline derivatives |
CS236097B1 (en) * | 1983-06-01 | 1985-05-15 | Jan Koenig | Acylderivatives of 2-piperazinochinazoline and method of their preparation |
AT384218B (de) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen chinazolin-derivaten |
US5110927A (en) * | 1987-12-31 | 1992-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Prazosin analog with increased selectivity and duration of action |
-
1994
- 1994-03-18 IT ITMI940506A patent/IT1270993B/it active IP Right Grant
-
1995
- 1995-03-17 PT PT95911342T patent/PT750614E/pt unknown
- 1995-03-17 WO PCT/EP1995/001001 patent/WO1995025726A1/en active IP Right Grant
- 1995-03-17 AT AT95911342T patent/ATE201400T1/de not_active IP Right Cessation
- 1995-03-17 JP JP52437095A patent/JP3683911B2/ja not_active Expired - Fee Related
- 1995-03-17 ZA ZA952208A patent/ZA952208B/xx unknown
- 1995-03-17 EP EP95911342A patent/EP0750614B1/en not_active Expired - Lifetime
- 1995-03-17 AU AU18948/95A patent/AU1894895A/en not_active Abandoned
- 1995-03-17 US US08/716,160 patent/US5798362A/en not_active Expired - Fee Related
- 1995-03-17 IL IL11302495A patent/IL113024A/xx not_active IP Right Cessation
- 1995-03-17 DK DK95911342T patent/DK0750614T3/da active
- 1995-03-17 DE DE69521037T patent/DE69521037T2/de not_active Expired - Fee Related
- 1995-03-17 ES ES95911342T patent/ES2158938T3/es not_active Expired - Lifetime
- 1995-05-23 TW TW084105132A patent/TW416951B/zh not_active IP Right Cessation
-
2001
- 2001-08-23 GR GR20010401292T patent/GR3036443T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE201400T1 (de) | 2001-06-15 |
IL113024A (en) | 2000-07-26 |
EP0750614B1 (en) | 2001-05-23 |
IL113024A0 (en) | 1995-06-29 |
JPH09511238A (ja) | 1997-11-11 |
ES2158938T3 (es) | 2001-09-16 |
DE69521037D1 (de) | 2001-06-28 |
AU1894895A (en) | 1995-10-09 |
US5798362A (en) | 1998-08-25 |
PT750614E (pt) | 2001-10-31 |
JP3683911B2 (ja) | 2005-08-17 |
WO1995025726A1 (en) | 1995-09-28 |
DE69521037T2 (de) | 2001-10-25 |
EP0750614A1 (en) | 1997-01-02 |
ITMI940506A1 (it) | 1995-09-18 |
GR3036443T3 (en) | 2001-11-30 |
ITMI940506A0 (it) | 1994-03-18 |
TW416951B (en) | 2001-01-01 |
ZA952208B (en) | 1995-12-28 |
IT1270993B (it) | 1997-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0750614T3 (da) | Quinazolinyl-aminoderivater med alfa-antagonist-aktivitet | |
BR0206985A (pt) | Anticorpos modificados e métodos de uso | |
ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
NO983707D0 (no) | Kinazolin-derivater som antitumor-midler | |
BR9609617B1 (pt) | derivados de 7h-pirrol[2,3-d]pirimidina, e composição farmacêutica. | |
BR0013966A (pt) | Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna | |
BR9811099A (pt) | Inibidores de urocinase | |
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
TR199801195T2 (xx) | Tedavide yararl� kinolin ve kinozilin bile�ikleri. | |
ATE171447T1 (de) | Benzimidazole derivate | |
DK0719154T3 (da) | Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel | |
BR0007589A (pt) | Inibidores da proliferação de células | |
EP0119161A3 (en) | Benzazoquinone and benzazoninone derivatives, process for their preparation, their pharmaceutical preparations as well as their therapeutic use | |
SE9703414D0 (sv) | New compounds | |
BR0206514A (pt) | Composto, método de tratamento de um ser humano ou animal que sofre de enxaqueca, uso do composto, composição farmacêutica, e, processo para preparar um composto | |
DE69533194D1 (de) | PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN | |
MX9700959A (es) | Derivados de becimidazol que tienen actividad dopaminergica. | |
TR200103550T2 (tr) | Faktör VIIa inhibitörler. | |
DK0986393T3 (da) | Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer | |
ATE216891T1 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
DK0758312T3 (da) | Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler | |
CZ157795A3 (en) | Pharmaceutical preparations for treating prostatitis |